Smoke of Endoscopic Gastrointestinal Surgery
SEGS
Composition, Hazard and Protection of Smoke From Endoscopic Gastrointestinal Surgery
1 other identifier
interventional
70
0 countries
N/A
Brief Summary
The purpose of this project is to study the composition, hazard, and protection of smoke from endoscopic gastrointestinal surgery. The study is a single-center, prospective, randomized, controlled, cohort study. The investigators plan to enroll 80 patients who undergo endoscopic gastrointestinal surgery and 10 medical staff participating in surgery in the gastrointestinal endoscopy room of the First Affiliated Hospital of Xi'an Jiao Tong University. The investigators will randomize the included study subjects. The investigators will monitore smoke and try to remove the smoke with an air sterilizer in the Air sterilizer group. The control group was monitored for smoke without any intervention. The primary endpoint is concentration of PM2.5 in smoke from endoscopic gastrointestinal surgery, the risk factors, and the effect of air sterilizer on its removal. The secondary endpoint is the concentration of PM1.0, PM10, formaldehyde, Total Volatile Organic Compounds, CO, and CO2 in smoke from endoscopic gastrointestinal surgery, the risk factors, and the effect of air sterilizer on its removal. Other exploratory objectives include the hazards of smoke to staff in the gastrointestinal endoscopy room, and the viral content of smoke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2022
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 24, 2022
CompletedFirst Posted
Study publicly available on registry
May 10, 2022
CompletedStudy Start
First participant enrolled
August 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2022
CompletedAugust 5, 2022
March 1, 2022
3 months
April 24, 2022
August 2, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
PM2.5 in smoke from endoscopic gastrointestinal surgery
Concentration of PM2.5 in smoke from endoscopic gastrointestinal surgery will be used by air quality testing equipment. The investigators will analyze the risk factors of PM2.5 related to surgery. The effect of air sterilizer on PM 2.5 removal will also be explored.
During the surgery.
Secondary Outcomes (1)
Some other harmful substances in smoke from endoscopic gastrointestinal surgery.
During the surgery.
Other Outcomes (2)
Hazards of smoke to staff in the gastrointestinal endoscopy room
During the surgery and 24 hours after the surgery.
Viral quantitative of smoke from endoscopic gastrointestinal surgery
40 minutes after surgery.
Study Arms (2)
Air sterilizer
EXPERIMENTALThe invesitigators will monitore smoke and try to remove the smoke with an air sterilizer during the endoscopic gastrointestinal surgery in the experimental group.
Control
NO INTERVENTIONThe control group was monitored for smoke during the endoscopic gastrointestinal surgery without any intervention.
Interventions
The invesitigators will try to remove the smoke with an air sterilizer during the endoscopic gastrointestinal surgery in the Air sterilizer group.
Eligibility Criteria
You may qualify if:
- Patients who undergo endoscopic gastrointestinal surgery and medical staff who participate in the surgery in the gastrointestinal endoscopy operating room of the First Affiliated Hospital of Xi'an Jiao Tong University
- Voluntary participation in this study
You may not qualify if:
- Severe liver disease
- Severe Kidney disease
- Severe cardiovascular disease
- Severe cerebrovascular disease
- Severe neuropsychiatric disease
- Unable to cooperate with the research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- STUDY DIRECTOR
Shuixiang He
First Affiliated Hospital of Xian Jiaotong University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2022
First Posted
May 10, 2022
Study Start
August 5, 2022
Primary Completion
October 31, 2022
Study Completion
November 30, 2022
Last Updated
August 5, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share
The invesitigators will conduct further research on endoscopic surgical smoke